Longstanding Eosinophilic Gastroenteritis of More Than 20 Years

Eosinophilic gastroenteritis (EGE) is an eosinophil-predominant inflammatory process that may be detected in endoscopic gastric or intestinal biopsies. The long-term natural history and effects of EGE treatment are not known. A 44-year-old man with abdominal pain was treated with oral ketotifen and...

Full description

Bibliographic Details
Main Author: Hugh J Freeman
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2009/565293
id doaj-87f69f17aadd474596abe254abc2e354
record_format Article
spelling doaj-87f69f17aadd474596abe254abc2e3542020-11-24T20:45:13ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002009-01-0123963263410.1155/2009/565293Longstanding Eosinophilic Gastroenteritis of More Than 20 YearsHugh J Freeman0Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, CanadaEosinophilic gastroenteritis (EGE) is an eosinophil-predominant inflammatory process that may be detected in endoscopic gastric or intestinal biopsies. The long-term natural history and effects of EGE treatment are not known. A 44-year-old man with abdominal pain was treated with oral ketotifen and followed for more than 20 years. Ketotifen provided symptomatic benefit, with prompt clinical relapse if the drug was discontinued. However, despite the use of ketotifen, the endoscopic abnormalities persisted and appeared to progress. Gastric body and antral mucosal folds appeared thickened, erythematous and friable, with minimal erosive change. Later, even during long asymptomatic periods suggesting clinical ‘remission’, inflammatory polypoid change, previously described in children with EGE, developed with mucosal ‘pock-marking’ and apparent scarring. Ketotifen treatment does not appear to prohibit or reverse the inflammatory process in the gastric mucosa in EGE, although long-term effects of steroids may be avoided. In the future, treatment of EGE may involve monoclonal antibody agents that target the specific biological effects of the eosino-phil, apparently central to this unusual inflammatory process.http://dx.doi.org/10.1155/2009/565293
collection DOAJ
language English
format Article
sources DOAJ
author Hugh J Freeman
spellingShingle Hugh J Freeman
Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
Canadian Journal of Gastroenterology
author_facet Hugh J Freeman
author_sort Hugh J Freeman
title Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
title_short Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
title_full Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
title_fullStr Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
title_full_unstemmed Longstanding Eosinophilic Gastroenteritis of More Than 20 Years
title_sort longstanding eosinophilic gastroenteritis of more than 20 years
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2009-01-01
description Eosinophilic gastroenteritis (EGE) is an eosinophil-predominant inflammatory process that may be detected in endoscopic gastric or intestinal biopsies. The long-term natural history and effects of EGE treatment are not known. A 44-year-old man with abdominal pain was treated with oral ketotifen and followed for more than 20 years. Ketotifen provided symptomatic benefit, with prompt clinical relapse if the drug was discontinued. However, despite the use of ketotifen, the endoscopic abnormalities persisted and appeared to progress. Gastric body and antral mucosal folds appeared thickened, erythematous and friable, with minimal erosive change. Later, even during long asymptomatic periods suggesting clinical ‘remission’, inflammatory polypoid change, previously described in children with EGE, developed with mucosal ‘pock-marking’ and apparent scarring. Ketotifen treatment does not appear to prohibit or reverse the inflammatory process in the gastric mucosa in EGE, although long-term effects of steroids may be avoided. In the future, treatment of EGE may involve monoclonal antibody agents that target the specific biological effects of the eosino-phil, apparently central to this unusual inflammatory process.
url http://dx.doi.org/10.1155/2009/565293
work_keys_str_mv AT hughjfreeman longstandingeosinophilicgastroenteritisofmorethan20years
_version_ 1716815042243985408